Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease
2024

Sleep Patterns in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

Sample size: 62 publication 10 minutes Evidence: moderate

Author Information

Author(s): Sofia Schaeffer, Andrijana Bogdanovic, Talitha Hildebrandt, Emilio Flint, Anne Geng, Sylvia Pecenko, Paul Lussier, Michael A. Strumberger, Martin Meyer, Jakob Weber, Markus H. Heim, Christian Cajochen, Christine Bernsmeier

Primary Institution: University of Basel, Basel, Switzerland

Hypothesis

Does metabolic dysfunction-associated steatotic liver disease (MASLD) affect sleep patterns compared to healthy controls?

Conclusion

Patients with MASLD experience fragmented nocturnal sleep characterized by increased wakefulness and reduced sleep efficiency.

Supporting Evidence

  • Patients with MASLD had more awakenings per night compared to healthy controls.
  • Patients with MASLD reported shorter sleep duration and poorer sleep quality.
  • Standardized sleep hygiene education did not improve sleep parameters.

Takeaway

People with a liver disease called MASLD have trouble sleeping well, waking up more often at night and feeling less rested.

Methodology

The study used actigraphy to objectively assess sleep-wake rhythms in 35 patients with biopsy-proven MASLD and 16 healthy controls over 4 weeks.

Potential Biases

Self-reported sleep data may be subject to reporting bias.

Limitations

The study had a small sample size and potential confounding factors such as BMI differences and undetected obstructive sleep apnea.

Participant Demographics

Participants included 35 patients with MASLD and 16 healthy controls, with a median age of 58 years for MASLD patients.

Statistical Information

P-Value

0.0036

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fnetp.2024.1458665

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication